PEROTTI, Paola Carla Giuseppina

PEROTTI, Paola Carla Giuseppina  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 2015 Ardito, A; Massaglia, C; Pelosi, E; Zaggia, B; Basile, V; Brambilla, R; Vigna-Taglianti, F; Duregon, E; Arena, V; Perotti, P; Penna, D; Terzolo, M.
A current perspective on treatment of adrenocortical carcinoma 2014 Massimo Terzolo, Silvia De Francia, Arianna Ardito, Paola Perotti, Laura Ferrari, Alfredo Berruti
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 2019 Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. 2018 Claps, Melanie; Cerri, Sara; Grisanti, Salvatore; Lazzari, Barbara; Ferrari, Vittorio; Roca, Elisa; Perotti, Paola; Terzolo, Massimo; Sigala, Sandra; Berruti, Alfredo
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 2019 Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M.
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 2023 Massimo Terzolo; Martin Fassnacht; Paola Perotti; Rossella Libé; Darko Kastelan; André Lacroix; Wiebke Arlt; Harm Reinout Haak; Paola Loli; Bénédicte Decoudier; Helene Lasolle; Marcus Quinkler; Magalie Haissaguerre; Olivier Chabre; Philippe Caron; Antonio Stigliano; Roberta Giordano; Maria Chiara Zatelli; Irina Bancos; Maria Candida Barisson Villares Fragoso; Letizia Canu; Michaela Luconi; Soraya Puglisi; Vittoria Basile; Giuseppe Reimondo; Matthias Kroiss; Felix Megerle; Stefanie Hahner; Otilia Kimpel; Tina Dusek; Svenja Nölting; Isabelle Bourdeau; Vasileios Chortis; Madeleine Hester Ettaieb; Deborah Cosentini; Salvatore Grisanti; Eric Baudin; Paola Berchialla; Francesca Bovis; Maria Pia Sormani; Paolo Bruzzi; Felix Beuschlein; Jerome Bertherat; Alfredo Berruti.
Adrenal cortical carcinoma: mitotane and beyond 2018 Silvia De Francia, Paola Perotti, Vittoria Basile, Antonina Germano, Massimo Terzolo
Adrenocortical Carcinoma with Hypercortisolism. 2018 Puglisi S, Perotti P, Pia A, Reimondo G, Terzolo M.
Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to alzheimer's disease 2007 PROLO P; CHIAPPELLI F; GRASSO E; ROSSO MG; NEAGOS N; DOVIO A; SARTORI ML; PEROTTI P; FANTÒ F; CIVITA M; FIORUCCI A; VILLANUEVA P; ANGELI A
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 2016 Reimondo, Giuseppe; Chiodini, Iacopo; Puglisi, Soraya; Pia, Anna; Morelli, Valentina; Kastelan, Darko; Cannavo, Salvatore; Berchialla, Paola; Giachino, Daniela; Perotti, Paola; Cuccurullo, Alessandra; Paccotti, Piero; Beck-Peccoz, Paolo; Marchi, Mario De; Terzolo, Massimo
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 2008 A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti
Chemotherapy 2011 Alfredo Berruti; Paola Sperone; Paola Perotti; Anna Ferrero; Luigi Dogliotti; and Massimo Terzolo
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 2018 Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo*
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 2018 Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M.
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 2019 Puglisi S, Pizzuto A, Laface B, Panero F, Aprà F, Palmas E, Perotti P, Reimondo G, Boccuzzi A, Terzolo M
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines 2009 Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A.
Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. 2007 Dovio A; Sartori ML; Perotti P; Abbadessa G; De Francia S; Bianco E; Racca S; Angeli A.
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 2017 Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 2009 DAFFARA Fulvia Claudia, ; DE FRANCIA SILVIA, ; Ardito, Arianna; Zaggia, Barbara; Fiori, C.; Angeli, Alberto; SCARPA Roberto Mario, ; Porpiglia, Francesco; Perotti, P.; Berruti, Alfredo; Terzolo, Massimo
Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors 2017 Henning J.E.K.; Deutschbein T.; Altieri B.; Steinhauer S.; Kircher S.; Sbiera S.; Wild V.; Schlotelburg W.; Kroiss M.; Perotti P.; Rosenwald A.; Berruti A.; Fassnacht M.; Ronchi C.L.